A recent study highlights a case of babesiosis presenting as secondary hemophagocytic lymphohistiocytosis in a patient undergoing B cell-depleting therapy. This finding underscores the need for awareness of atypical presentations of babesiosis in immunocompromised patients.
babesiosis at ultra low parasitemia presenting as secondary hemophagocytic lymphohistiocytosis in a patient on b cell depleting therapy
Original title: “Babesiosis at ultra-low parasitemia presenting as secondary hemophagocytic lymphohistiocytosis in a patient on B cell-depleting therapy.”